PLoS ONE
Home Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study
Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study
Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study

Article Type: correction Article History
The PLOS ONE Staff: Correction: Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study

Notice of republication

This article was republished on December 11, 2020, to correct errors in the Qualitative interviews subsection of the Results section that were introduced during the typesetting process. The publisher apologizes for the errors. Please download this article again to view the correct version. The originally published, uncorrected article and the republished, corrected articles are provided here for reference.

Reference

JTPrice, CMMabula-Bwalya, BLFreeman, JCarda-Auten, WMPhiri, KChibwe, et al (2020) Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study. PLoS ONE 15(9): e0238748 10.1371/journal.pone.0238748